搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
4 天
领”享】FDA将讨论PD-L1作为检查点抑制剂的预测性biomarker的问题
FDA在一份公告中提到,累积数据表明,PD-L1蛋白质的表达水平可以被用来预测某些胃癌、胃食管结合部癌症和食管鳞状细胞癌患者使用免疫检查点抑制剂的疗效。然而,像默沙东的Keytruda和百时美施贵宝的Opdivo这样的重磅药物已经获准用于更广泛的患者群体,不考虑PD-L1的状态。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Alabama mass shooting
On running again in 2028
Daylight saving time
Robinson loses key staff
Ga. suspect's mom indicted
California plastic bag ban
To skip Al Smith dinner
San Francisco homelessness
CAH sues for trespassing
Biden hosts 'Quad' summit
Suns broadcaster dies
Free COVID-19 tests
ISR raids Al Jazeera office
House repeals emission rules
No. 1 at box office again
Former WA governor dies
Donlon's homes searched
CA firefighter held for arson
Released after guilty plea
CA bill to protect kids online
J&J unit files for bankruptcy
Drug price challenge revived
TN abortion law blocked
Pandas leaving for China
FDA approves flu vaccine
Iran coal mine blast
Boeing defense chief exits
SC 1st execution in 13 years
Hezbollah rockets hit Israel
Sesame Place suit verdict
PM Modi visits US
反馈